IQVIA presents a fresh analytical report highlighting the key trends in the pharmaceutical markets of Eurasian countries, including Kazakhstan. Discover:
- Which markets demonstrated the highest growth dynamics.
- The share of retail and public segments in total sales.
- Market leaders among companies and brands, with rankings based on sales volumes.
- Insights into trends, including the development of Rx and OTC products.
- Forecasts based on IQVIA’s global and local data.
The retail segment dominates the pharmaceutical markets of Eurasia, with prescription (Rx) products accounting for up to 70% of total sales. Kazakhstan stands out as the leading market in the region and is the only country where government procurement represents over 40% of the market’s total sales.
Check out the full report: